Katheryne Richardson, PharmD

Vice President, Global Pricing and Health Systems Analytics at Bristol Myers Squibb

Speaker

I joined Bristol Myers Squibb in June 2021 as Executive Director 340B Strategy. In 2023, I was appointed Vice President Global Healthcare Strategy and Analytics where I collaborated across the organization to drive alignment cross-functionally, and in supporting BMS teams in ongoing external interactions with our customers, payers, and trade groups on highly complex topics such as 340B and the Inflation Reduction Act (IRA). In April 2024, I assumed the position of Vice President, Global Pricing and Health Systems Analytics. I am responsible for leading US and WW pricing, which includes pricing execution and contract operations, government pricing, and pricing policy analytics functions.

Prior to joining Bristol-Myers Squibb, I was Vice President of Apexus, the 340B Prime Vendor Program, where I was responsible for the executive oversight of teams responsible for policy, education, and compliance. As a recognized thought-leader, I led teams that created industry 340B standard-setting programs and served on the senior leadership team responsible for the strategic direction, financial oversight, and overall business operations of the company.

I am a graduate of the University of Kentucky College of Pharmacy, receiving my B.S. and PharmD degrees. I am a licensed pharmacist in Virginia and Florida. I also hold a certification in Health Economics and Outcomes Research from the American Society of Health System Pharmacists.

Currently reside in Virginia Beach, Virginia, with my husband and six children.